Evidence map›Paper›PMID 42597581›Full record

ArticleFrontiers in immunology2026

LM-QASAS: reference-free identification of antigen-specific sequences from the BCR repertoire using antibody language models.

Genki Masuda, Yohei Funakoshi, Shunsuke Iizumi, Kimikazu Yakushijin, Goh Ohji, Hironobu Minami, Masahito Ohue

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Genki Masuda *Department of Computer Science, School of Computing, Institute of Science Tokyo, Yokohama, Kanagawa, Japan.
Yohei Funakoshi *Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital, Kobe, Hyogo, Japan.
Shunsuke Iizumi *Department of Computer Science, School of Computing, Institute of Science Tokyo, Yokohama, Kanagawa, Japan.
Kimikazu YakushijinDivision of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital, Kobe, Hyogo, Japan.
Goh OhjiDivision of Infection Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Hospital, Kobe, Hyogo, Japan.
Hironobu MinamiDivision of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital, Kobe, Hyogo, Japan.
Masahito OhueDepartment of Computer Science, School of Computing, Institute of Science Tokyo, Yokohama, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The B-cell receptor (BCR) repertoire serves as a historical record of immunological events. However, deciphering antigen-specific sequences from this vast dataset remains a challenge, particularly for novel pathogens where prior knowledge is absent. While time-course analysis methods such as QASAS have proven effective for tracking immune responses, they rely on existing antibody databases, limiting their applicability to emerging diseases. To overcome this limitation, we introduce LM-QASAS, a reference-free computational framework that integrates antibody language models (AbLMs) with longitudinal repertoire dynamics. By mapping sequences into a high-dimensional semantic embedding space, LM-QASAS identifies clusters of functionally convergent sequences that are semantically similar and exhibit transient expansion upon immune stimulation. In a SARS-CoV-2 cohort, candidate sequences extracted by LM-QASAS were enriched for overlap with the CoV-AbDab neutralizing-antibody database relative to a random baseline. Leave-one-out cross-validation showed that these reference-free databases could reconstruct longitudinal immune-response dynamics in unseen individuals without external references. Conversely, the method showed limited sensitivity in an influenza vaccine cohort, indicating that the approach is most effective under conditions of robust, synchronized clonal expansion, such as those induced by mRNA vaccination. LM-QASAS provides a rapid, reference-free approach for monitoring humoral immunity against emerging threats.

Indexed as

Antibodies, ViralCOVID-19Receptors, Antigen, B-CellSARS-CoV-2Antibodies, NeutralizingHumansImmunoinformaticsAntibodies, NeutralizingAntibodies, ViralReceptors, Antigen, B-CellAI and machine learningantibody language modelB-cell receptor repertoireSARS-CoV-2systems immunology

Identifiers

PMID42597581
PMCPMC13468803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.